Skip to content

Clinical trials

Phase 1/2 Heart Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Diseases Phase: Phase 1/2 Country / region: United States Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20111
20141
20151
20191
20202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated2
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celladon Corporation1
John J Freiberger1
Microvascular Therapeutics, LLC1
National Heart, Lung, and Blood Institute (NHLBI)1
Thomas Advanced Medical LLC1
University of Pennsylvania1
Vanderbilt University1
XyloCor Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Diseases8
Cardiovascular Diseases6
Cardiomyopathies2
Heart Defects, Congenital2
Heart Failure2
Alzheimer Disease1
Angina Pectoris1
Autoimmune Diseases1
Brain Diseases1
COVID-191

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.